Skip to main contentSkip to footer

STERIS AST announces sustainable EO sterilization services

December 21, 2017

As part of our commitment to providing innovative and sustainable solutions, STERIS AST is pleased to announce our newest offering, Sustainable EOSM sterilization services.

Our Sustainable EO services provide Customers with strategies to reduce the EO sterilant used in the sterilization process to achieve the prescribed Sterility Assurance Level.  The program includes innovative approaches to EO sterilization, such as cycle design, validation strategy, and process challenge device design, all focused on the reduction of EO residuals on healthcare products.

Optimized sterilant input provides several benefits, including:

  • Lower product residuals to meet current and future patient safety requirements
  • Improved occupational safety
  • Improved supply chain efficiencies due to reduced aeration (off-gassing) of ethylene oxide gas

“The Sustainable EO service supports our commitment to providing a safe and compliant work environment for our People and discovering innovative ways to service our Customers,” comments Dan Carestio, Senior Vice President of STERIS AST. “This unique service is an example of our passion for continuous improvement as part of our global technology-neutral sterilization offering.”

Go here to learn more about Sustainable EO sterilization services.

Sustainable-EO-Scorecard-2.21-300x135

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life sciences products and services. For more information, visit www.steris.com.

 
Related Posts
Exterior View of STERIS Facility in Batu Kawan, Malaysia
May 1, 2025

As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce a new ethylene oxide (EO) processing facility in Batu Kawan industrial Park in Penang, Malaysia.

202310-LibertyvilleIL-Lab-5
March 28, 2025
March 28, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS Applied Sterilization Technologies (AST) is pleased to announce the addition of Extractables and Leachables (E&L) testing, featuring advanced chemical analysis.
New-Swindon-Lab-1-600x600
February 5, 2025
February 5, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS is pleased to announce our South Marston, UK laboratory has relocated to Swindon, UK. The new laboratory supports the increased demand in volume and complexity of medical devices and pharmaceuticals in the region.
STERIS is pleased to announce our brooklyn park mn usa laboratory now offers bacteria
January 10, 2025
January 10, 2025 – As part of our long-term commitment to supporting global healthcare product manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota, USA laboratory now offers a sustainable approach to bacterial endotoxin testing through the use of recombinant cascade reagents.